Zbigniew Herman

Q: What Schools Are Affiliated With Zbigniew Herman

Zbigniew Herman is affiliated with the following schools: Medical University of Warsaw, Medical University of Silesia

Zbigniew Herman's AcademicInfluence.com Rankings

Zbigniew Herman

Medical

#1952

World Rank

#2340

Historical Rank

Pharmacology

#488

World Rank

#547

Historical Rank

medical Degrees

Zbigniew Herman

Philosophy

#11414

World Rank

#15711

Historical Rank

Logic

#8231

World Rank

#10266

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Zbigniew Herman's Degrees

Doctorate Medicine Medical University of Warsaw
PhD Pharmacology Medical University of Warsaw

Why Is Zbigniew Herman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Zbigniew Stanisław Herman was a Polish physician and pharmacologist, rector of Silesian Medical Academy in years 1980–1982. He was decorated with an Officer's Cross and with a Commander's Cross with Star of Polonia Restituta.

(See a Problem?)

Zbigniew Herman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cytokines in schizophrenia and the effects of antipsychotic drugs (2006) (230)
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. (1998) (173)
Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia (2001) (115)
Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. (2005) (107)
Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes (2012) (98)
Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. (1999) (89)
Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. (2006) (87)
The effects of noradrenaline on rat's behaviour (2004) (68)
Monocyte Release of Tumor Necrosis Factor-α and Interleukin-1β in Primary Type IIa and IIb Dyslipidemic Patients Treated With Statins or Fibrates (2005) (66)
The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. (2004) (63)
[Current pharmacotherapy of obesity]. (2000) (61)
Chlorpromazine and loxapine reduce interleukin-1β and interleukin-2 release by rat mixed glial and microglial cell cultures (2004) (59)
Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. (2001) (58)
Update on the management of polycystic ovary syndrome. (2006) (45)
Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. (2005) (42)
BEHAVIOURAL CHANGES INDUCED IN CONSCIOUS MICE BY INTRACEREBROVENTRICULAR INJECTION OF CATECHOLAMINES, ACETYLCHOLINE AND 5‐HYDROXYTRYPTAMINE (1975) (39)
Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? (2004) (38)
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb. (2001) (34)
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. (2003) (34)
[Adipose tissue: a new endocrine organ]. (2005) (33)
Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone (2000) (33)
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia. (2001) (33)
Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-α and nitric oxide by rat microglial cells (2003) (32)
Monocyte suppressing action of fenofibrate. (2005) (32)
Effect of Monthly Atorvastatin and Fenofibrate Treatment on Monocyte Chemoattractant Protein-1 Release in Patients with Primary Mixed Dyslipidemia (2005) (28)
Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. (2004) (25)
Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia (2003) (24)
Immunophilin ligands decrease release of pro-inflammatory cytokines (IL-1beta, TNF-alpha and IL-2 in rat astrocyte cultures exposed to simulated ischemia in vitro. (2004) (24)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency (2006) (22)
Extralipid effects of micronized fenofibrate in dyslipidemic patients. (2006) (21)
[Somatostatin analogs]. (2006) (21)
Behavioural effects of dibutyryl cyclic 3',5' AMP, noradrenaline and cyclic 3',5' AMP in rats. (1973) (21)
Neuropeptide Y in obese women during treatment with adrenergic modulation drugs. (2001) (20)
Quality of life in cancer patients treated by chemotherapy. (2000) (20)
Central Effects of Tuftsin (1983) (19)
Hypolipidemic Drugs Affect Monocyte IL-1β Gene Expression and Release in Patients with IIa and IIb Dyslipidemia (2005) (18)
Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain (1999) (18)
The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behaviour in the rat (2004) (17)
Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia. (2004) (17)
Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation. (2011) (15)
Influence of some psychotropic and adrenergic blocking agents upon amphetamine stereotyped behaviour in white rats (2004) (15)
In-vitro Immunomodulatory Effects of Haloperidol and Perazine in Schizophrenia (2000) (15)
[Pleiotropic effects of fibrates]. (2001) (15)
Effects of cholinomimetics, cholinolytics and atypical antidepressants in the behavioral despair test in the rat. (1981) (15)
Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. (1987) (14)
Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages (2000) (14)
Role of corticotropin-releasing factor (CRF) in anxiety. (2000) (14)
Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain. (2006) (14)
Antinociceptive effects of puromycin and bacitracin. (1985) (13)
Tuftsin and D-Arg3-tuftsin possess analgesic action (1981) (13)
Influence of antidepressant drugs on macrophage cytotoxic activity in rats. (2004) (13)
Plasma cytokines as predictors of coronary heart disease. (2002) (12)
Changes of certain pharmacological and biochemical indices in acute methylglyoxal poisoning. (1975) (12)
Recent insights into body weight control: From physiology to pathology (2001) (12)
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice (2003) (12)
Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage. (1998) (11)
Carbon monoxide: a novel neural messenger or putative neurotransmitter? (1997) (11)
Behaviour of rats and biogenic amine level in brain after 6-hydroxy-dopamine (2004) (10)
[Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia]. (2002) (10)
Enkephalin content in rat striatum during prolonged treatment with fluphenazine (1984) (10)
Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons (1997) (10)
A new immunological marker of atherosclerotic injury of arterial wall. (2001) (9)
Amitriptyline and nortriptyline inhibit interleukin-1 b and tumour necrosis factor- a release by rat mixed glial and microglial cell cultures (2005) (9)
[Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy]. (1998) (9)
The risk of atherosclerosis in patients with impaired glucose tolerance. (2003) (8)
Effect of monthly atorvastatin treatment on hemostasis. (2004) (8)
Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1β levels in the rat brain (2006) (8)
Behavioral effects of norepinephrine and dibutyryl 3',5'AMP in centrally sympathectomized rats. (1974) (8)
Antitumor activity of bestatin and thiorphan in mice. (1995) (8)
Methionine-enkephalin and leucine-enkephalin increase interleukin-1β release in mixed glia cultures (2002) (8)
Carbon monoxide: a novel neural messenger or putative neurotransmitter? (1997) (8)
Analgesic activity of some tuftsin analogs (1980) (7)
Atrial natriuretic peptide secretion following subarachnoid hemorrhage in spontaneously hypertensive rats. (1996) (7)
Concentration of enkephalins in cerebrospinal fluid of patients after severe head injury (1997) (7)
Amphetamine-induced effects on neuropeptide Y in the rat brain. (2005) (7)
Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin (2004) (7)
To the problem of biologically active conformation of enkephalin (1981) (7)
The influence of 1-(o-Allylphenoxy)-3-Isopropylamino-2-Propanol Hydrochloride (Alprenolol) on the central nervous system of the rat (2004) (7)
The influence of the kappa agonist-spiradoline (U62066E) on the analgesic activity of some opioids at the spinal level. (1994) (7)
Central effects of prostaglandin D2. (1980) (7)
Application of calcium channel blockers in the treatment of cardiovascular diseases. (1999) (7)
Interaction on the antinociceptive effect between neurotensin and enkephalins or tuftsin. (1984) (6)
Effect of prostaglandins on chloropromazine induced catalepsy in mice. (1983) (6)
EFFECTS OF GAP SIZE AND LOCATIONS ON THE REGENERATION OF CASTANOPSIS KAWAKAMII IN A SUBTROPICAL NATURAL FOREST, CHINA (2018) (6)
Mediation of central prostaglandin effects by serotoninergic neurons (1979) (6)
Enkephalin analogs modified in the aromatic ring of the N-terminal tyrosine residue (1979) (6)
Effects of chronic oral administration of imipramine in the rat forced swimming test. (1986) (5)
Effects of psychotropic drugs on exploratory behavior of mice. (1974) (5)
The influence of antidepressive drugs on the level of acetylcholine and on the acetylcholinesterase activity in the brain of rats. (1976) (5)
Analgesic activity of enkephalin analogues containing aminophosphonic acid residues at C-terminal position (2004) (5)
Pharmacological interaction between neuropeptides and morphine or pentazocine in rat spinal cord. (1991) (5)
Leu-enkephalin content in rat brain during prolonged treatment with imipramine or amitriptyline (1986) (5)
ON UNDERSTANDING THE HARDIN JONES-PAULING BIOSTATISTICAL THEORY OF SURVIVAL ANALYSIS FOR CANCER PATIENTS (1998) (5)
Influence of 6-hydroxydopamine on the behavioral effects induced by apomorphine or clonidine in rats (1976) (5)
Central action of cyclic: 3',5'-thymidine, 3',5'-uridine and 3',5'-citidine monophosphates in rat. (1984) (5)
Basic pharmacological properties of a novel antiinflammatory drug tryptamide. (1987) (5)
Captopril augments antitumor activity of cyclophosphamide in mice. (1996) (5)
Diuretic effects of intraventricularly injected noradrenaline and dopamine in rats (1974) (5)
The impairment of learning of conditioned avoidance response in rats after 6-hydroxydopamine. (1975) (5)
[Growth hormone deficiency in children and adults]. (2005) (5)
Effects of thiorphan, bestatin and captopril on the Lewis lung carcinoma metastases in mice. (1995) (5)
Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs. (1990) (5)
[Gonadotropin-releasing hormone analogs]. (2005) (4)
Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity (2005) (4)
[Antidepressants and cytokines--clinical and experimental studies]. (2005) (4)
Progress and dilemma of contemporary clinical pharmacology. (2005) (4)
Potentiation of cataleptogenic effects of neuroleptics by prostaglandins. (1978) (4)
Effect of enflurane on selected neuropeptides and marker enzymes in rabbit brain. (1998) (4)
Synthesis and Structure-Activity Relationship of Scyliorhinin I Analogues Modified in Position 3, 6, 7 and 8 (1993) (4)
Influence of isoflurane on enkephalin levels and on some indicatory enzymes in the central nervous system of rabbits. (1997) (4)
Behavioural and biochemical effects of 6-hydroxydopa in rats (1974) (4)
[Markers of inflammatory process in stable and unstable coronary artery disease]. (2006) (4)
Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants (2003) (3)
Effect of phenothiazine neuroleptic drugs and tricyclic antidepressants on phosphodiesterase activity in rat cerebral cortex (2004) (3)
Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain. (1993) (3)
Model of central chemical 'serotoninectomy' in mice. (1978) (3)
Neuropeptide Y (NPY) and its mRNA in discrete brain areas after subchronic administration of neuroleptics. (1996) (3)
Rapid test for screening of narcotic analgesics in mice. (1979) (3)
[An unusual clinical presentation of the autoimmune polyendocrine syndrome]. (2005) (3)
Influence of ketamine and its interactions with morphine and nalbuphine on the level of enkephalins in some parts of the brain and spinal cord. (1994) (3)
[Subclinical thyroid disorders]. (2006) (3)
Biological activity of TRH thionalogue and its diastereoisomers. (1987) (3)
Increased aggression in rats after withdrawal of long term used oxazepam (1976) (3)
Hypothalamic, striatal and plasma leucine enkephalin level in two rat models of portal hypertension. (1993) (3)
Application of calcium channel blockers in the treatment of cardiovascular diseases. (1999) (3)
Central effects of prostaglandins F2alpha and E1. (1976) (3)
Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus. (1979) (3)
Behavioral effects of withdrawal of fluphenazine after long-term treatment. (1976) (3)
Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain (2005) (3)
Central cholinergic receptor supersensitivity after long-term atropine administration (1979) (3)
Pharmacological interaction between neuropeptides and pethidine or fentanyl in rat spinal cord. (1993) (3)
Progress and dilemma of contemporary clinical pharmacology. (2005) (3)
Antinociceptive and behavioral effects of leu-enkephalin (LENK) or D-Ala2-met-enkephalinamide (DAMEA) in rats after central chemical sympathectomy or serotoninectomy. (1985) (2)
Effect of prostaglandin synthesis inhibition on the central activity of noradrenaline in rats. (1981) (2)
[Recent insights into the role of aldosterone in physiology, pathology and therapy]. (2005) (2)
Studies on the behavioral and hypotensive effects of intraventricular prostacyclin (PGI2) in rats. (1981) (2)
The influence of adrenaline and optical isomers INPEA on the adenylcyclase activity in brain hemispheres of rats in vitro. (1970) (2)
The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins. (1993) (2)
Effect of substituted benzamides on feeding and hypothalamic neuropeptide Y-like immunoreactivity (NPY-LI) in rats (2001) (2)
Agmatine--a novel endogenous ligand of imidazoline receptors. (1997) (2)
Progress in pharmacotherapy of thrombosis. (2003) (2)
THE APPLICATION OF THE HARDIN JONES-PAULING BIOSTATISTICAL THEORY OF SURVIVAL ANALYSIS FOR CANCER PATIENTS TO A CLINICAL TRIAL PURPORTING TO TEST THE EFFICACY OF VITAMIN C IN LENGTHENING THE SURVIVAL TIMES OF PATIENTS WITH AD VANCED COLORECTAL CANCER (1998) (2)
5-hydroxydopamine, unspecific centrally acting false neurotransmitter. (1977) (2)
l-Prolyl-l-arginine fragment of tuftsin peptide chain elicits analgesic action (1985) (2)
[Rare pancreatic endocrine tumors]. (2008) (2)
Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension. (1998) (2)
Influence of neuroleptics on cytotoxic activity of macrophages in rats. (1998) (2)
Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1 beta levels in the rat brain. (2006) (2)
The principles of controlled clinical trials of drugs. (1978) (2)
Neuropeptide Y-like immunoreactivity in lumbar cerebrospinal fluid of patients after severe head trauma (1997) (2)
Influence of noradrenaline, 5-hydroxytryptamine and acetylcholine injected intraventricularly on the rat's behaviour. (1973) (2)
Agmatine--a novel endogenous ligand of imidazoline receptors. (1997) (2)
Synthesis and biological activity in GPI test of scyliorhinin I and its analogues modified in position 8 by Leu, Sar and Pro residues (1991) (2)
Further investigations on the antinociceptive activity of tuftsin analogs. (1991) (2)
[Selective estrogen receptor modulators]. (2002) (2)
[Thyroid disorders in pregnancy and after delivery]. (2007) (2)
The effect of a single temazepam administration on enkephalin content in the striatum and hypothalamus of the rat. (1983) (2)
The cholinergic system of the brain and its interactions with other aminergic systems. (1979) (2)
Corrigendum to "Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation" [Pharmacol. Rep. 63 (2011) 392-402]. (2018) (2)
Influence of halothane on the level of enkephalins in discrete brain areas of rabbits. (1995) (2)
The activation of the renin--angiotensin system in the dog after injection of noradrenaline into the lateral brain ventricle. (1975) (2)
Central effects of D-Ala2-met-enkephalinamide on the blood pressure of rats after central chemical sympathectomy or serotoninectomy. (1985) (2)
Extralipid effects of hypolipidemic drugs – why do clinical trials weakly support experimental data ? (2007) (2)
The dihydropyridines modulate neurotensin inotropic action paradoxically. (1995) (2)
Effect of neuroleptics on release on acetylcholine to the lateral cerebral ventricle in the rat. (1981) (2)
The lack of affinity of prostaglandins to dopaminergic and opiate receptors in the rat striatum. (1980) (1)
Central action of catecholamines on the cardiovascular system in rats. (1978) (1)
The activation of the renin--angiotensin system in the dog after injection of noradrenaline into the lateral brain ventricle. (1975) (1)
Studies on adrenergic mechanisms in the action of desmethyl imipramine (DMI) (2004) (1)
[S-α-Methylserine2]enkephalins elicit a potent long lasting antinociceptive effect (1993) (1)
[The role of neuropeptide Y in anxiety]. (2001) (1)
[Prostate cancer chemoprevention]. (2005) (1)
[Disorders of dopamine and 5-hydroxytryptamine metabolism in the early period after cranio-cerebral injuries]. (1979) (1)
Effects of dibutyryl cyclic GMP on the content of biogenic amines in discrete areas of brain and on the behaviour of rats. (1978) (1)
[Pharmacological effects of neurotensin, substance P and tuftsin]. (1985) (1)
Influence of dibutyryl cyclic AMP on the level of catecholamines and 5-hydroxytryptamine in discrete areas of rat brain. (1977) (1)
Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine). (1973) (1)
Tentative treatment of experimental toxoplasmosis in mice. IX. Effect of trimethoprim, sulfo-methoxazole and their combination Septrin. (1974) (1)
Behavioural effects of two dipeptides L-phenyl analyl-L-arginine (Phe-L-Arg) and L-phenyl alanyl-D-arginine (Phe-D-Arg) after intracerebroventricular or intrathecal injections in mice (1992) (1)
[The values of selected lipid parameters and atrial pressure in persons with hyperinsulinemia and normal glucose tolerance]. (1998) (1)
New vistas in immunopsychopharmacology. (1998) (1)
Role of the noradrenergic and the dopaminergic receptors in the mechanism of the avoidance reflex in rats. (1975) (1)
New vistas in immunopsychopharmacology. (1998) (1)
The influence of 6-hydroxydopamine and 6-hydroxydopa on the phospholipids content in the brain of rats. (1979) (1)
Reactivity of isolated human right atria to norepinephrine in various disease states. (1995) (1)
Behavioral effects of two dipeptides: L-phenylalanyl-L-arginine (Phe-L-Arg) and L-phenylalanyl-D-arginine (Phe-D-Arg) injected into the striatum or substantia nigra of rats. (1985) (1)
The analgesic activity of some kyotorphin-tuftsin analogs. (1990) (1)
Behavior of rats at different phases of the sexual cycle (1974) (1)
Behavioral effects of dibutyryl cyclic 3'5'AMP and biogenic amines in rats. (1975) (1)
[Hyperthyroidism in pregnancy]. (2006) (1)
Influence of noradrenaline, 5-hydroxytryptamine and acetylcholine injected intraventricularly on the rat's behaviour. (1973) (1)
The cholinergic system of the brain and its interactions with other aminergic systems. (1979) (1)
[Pharmacological effects of neurotensin, substance P and tuftsin]. (1985) (1)
The application of mydriatic effect of enkephalins in mice as a test for screening of opioid peptides. (1986) (1)
[Advances in the diagnosis and treatment of Zollinger-Ellison syndrome]. (2012) (1)
Comparison of central and peripheral action of F2 alpha prostaglandin on the circulation of rat and guinea pig. (1981) (1)
[Advance in treatment of polycystic ovary syndrome]. (2005) (1)
[Anabolic therapy in osteoporosis--part 1]. (2005) (1)
Central effects of dibutyryl cyclic 3',5' AMP and dibutyryl cyclic 3',5' GMP in mice. (1977) (1)
[Verapamil-induced hyperprolactinemia--a case report]. (2005) (1)
[Incidentaloma--one of the greatest challenges of modern endocrinology]. (2006) (1)
Evolution of understanding of the mechanism of antidepressants (AD) and pharmacological treatment of major depression (MAJ) (2010) (1)
[Thyroid hormone resistance syndrome]. (2006) (1)
Central effects of acetylcholine (2004) (1)
[THE EFFECT OF SEROTONIN ON ELECTROCARDIOGRAPHIC CURVES OF PIGEONS]. (1964) (1)
673 – CENTRAL EFFECTS OF PROSTAGLANDINS /PG/ F2α AND E1 (1977) (1)
The effect of certain neurotransmitters on the analgesic action of enkephalinamide. (1982) (1)
[Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)]. (1980) (1)
The effect of the chronic L-adrenaline, D, L-metanephrine and L-thyroxine administration on the MAO activity in rat's brain. (1974) (1)
Effects of acute or multiple administrations of neuroleptics, on neuropeptide Y system in the rat nucleus accumbens (1995) (1)
The effect of chemical sympathectomy of central nervous system on the duration of barbital-induced sleep in rats. (1975) (1)
[Current concepts on diagnosis and treatment of carcinoid]. (2007) (1)
The influence of biogenic amines and cyclic nucleotides on rats' bhavior after the chemical serotoninectomy of the central nervous system. (1978) (1)
[Nephrogenic diabetes insipidus induced by colchicine--a case report]. (2005) (1)
Effect of stimulation or inhibition of muscarinic or nicotinic receptors on the content of biogenic amines in various parts of rat brain. (1983) (1)
The level of total acetylcholine in discrete brain areas and behavior of rats after neuroleptics. (1975) (1)
Influence of nifedipine on aortal cholesterol content, blood coagulation and elastin metabolism in cholesterol-fed rabbits. (1992) (0)
[Importance of the discovery of endorphins and enkephalins for present-day psychopharmacology]. (1983) (0)
[Monogenic forms of mineralocorticoid hypertension]. (2004) (0)
[Mechanisms of non-lipid dependent effects of statins]. (2002) (0)
[Role of catecholamines and their metabolism in the activity of the brain]. (1971) (0)
Acute toxicity and the influence of some undecane, cyclopentylpentane and pyridine alpha- and beta-carboxylic acid derivatives on the increased hyperlipemia in rats. (1975) (0)
The effects of mecholyl and atropine on the muscarinic receptors in rat small intestine after long-term atropine administration in vivo. (1982) (0)
Vinpocetine exerts cytoprotective activity and prevents apoptosis of astrocytes during in vitro ischemia and reoxygenation (2003) (0)
Effect of D-Ala2-met-enkephalinamide and morphine on the activity of choline acetyltransferase and acetylcholinesterase in rat brain. (1981) (0)
Influence of chemical cerebral sympathectomy on behavioural effects of acetylcholine and neuroleptics in rats. (1975) (0)
[The analysis of rationale in antibiotic usage in certain maternity and gynecological wards and analogous outpatient clinics]. (1997) (0)
[Primary aldosteronism--new insight into an old disease]. (2004) (0)
Action of biogenic amines injected intracerebrally on duration of hexobarbital-induced sleep in rats. (1975) (0)
A study of some psychotropic drugs with the Burn-Hobbs test. (1961) (0)
The influence of central chemical sympathectomy and reserpine on peripheral effects of noradrenaline and cyclic AMP dibutyrate injected into the cerebral ventricles. (1976) (0)
[Primary aldosteronism]. (2007) (0)
Leu-enkephalin content in rat brain during prolonged treatment with imipramine or amitriptyline. (1986) (0)
Eticlopride modifies the food intake by its influence on neuropeptide Y in the hypothalamus (1995) (0)
The influence of ATP and AMP injected into the lateral ventricles of the brain on behavior in rats. (1976) (0)
Opiate-like peptides. Part XIII. Synthesis and analgesic activity of met-enkephalin analogs substituted in position 4 with D-4-halogenophenylalanine. (1991) (0)
The role of catecholamines and acetylcholine in the regulation of animal behaviour. (1980) (0)
30 years of the Ludwik Waryński Silesian Medical Academy--the history and development of the department of pharmacology. (1978) (0)
The diuretic action of noradrenaline and dopamine in rats with chemical serotoninectomy and central nervous system sympathectomy. (1983) (0)
Influence of polyphloretin phosphate on the central effects of prostaglandin E2 and F2α in rats (1978) (0)
[Chemical agents exerting specific adverse effects on neurons synthesizing biogenic amines]. (1978) (0)
Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period. (1986) (0)
5-HYDROXYTRYPTAMINE AND MULTIPLE SCLEROSIS (1961) (0)
[Detectable plasma markers of atherosclerotic artery injuries]. (2001) (0)
Antitumor activity of bestatin and tiorphan — inhibitors of enzymatic degradation of enkephalins in mice (1992) (0)
[Effect of alprenolol and alprenolol combined with amphetamine on the brain of rats]. (1972) (0)
[Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid from the lateral ventricle of patients with brain tumors]. (1986) (0)
[Differences in pharmacokinetic and pharmacodynamic processes in elderly patients]. (1989) (0)
[A rare association of postpartum thyroiditis and ulcerative colitis]. (2005) (0)
[Atherosclerotic injury to arteries in patients with chronic infections--immunopathologic factors and risk of coronary disease]. (1997) (0)
Tentative treatment of experimental toxoplasmosis in mice. VIII. Effect of üulfamethoxypyrazine-pyrimethamine combination and effect of suifamethc xypyrazine-longum in the treatment of experimental toxoplasmosis in the nouse. (1970) (0)
[Aromatase inhibitors]. (2004) (0)
Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats. (1995) (0)
The effects of multiple administration of neuroleptics on neuropeptide Y content in the rat hypothalamus (1995) (0)
[Influence of thyroxine and drugs used in the treatment of thyreotoxicosis on the level of catecholamines in different parts of rat's brain]. (1970) (0)
[Effect of prolonged administration of amphetamine on the weight and macroscopic appearance of internal organs in rats]. (1972) (0)
[Modern pharmacotherapy of benign prostatic hyperplasia]. (2005) (0)
Effect of prostaglandins on morphine-induced catalepsy in mice. (1983) (0)
BDNF/TrkB mRNA expression following antidepressants action in striatal astroglial cells (2010) (0)
Effect of 6-hydroxydopamine on the duration of hexobarbital sleep in rats (2005) (0)
Tentative treatment of experimental toxoplasmosis in mice. VII. Effect of some sulphonamides applied with DMSO and doxycycline, methacycline, Sanasil, amantadme and bithionol on the course of subacute toxoplasmosis. (1970) (0)
[Normoaldosterone spironolactone sensitive hypertension--a case report]. (2005) (0)
Atherosclerotic lesions induced by loustalot's diet in rats treated with Benzmalecene. (1967) (0)
Choline acetyltransferase and acetylcholinesterase activities in mice brain during the antagonistic action of antidepressant drugs and Ro 4--1284. (1978) (0)
Influence of meptazinol on levels of biogenic amines in discrete brain areas of rats. (1988) (0)
Enkephalins and the action of psychotropic drugs. (1987) (0)
The influence of psychotropic drugs on the level and metabolism of noradrenaline in brain and behavior of rats. (1970) (0)
[The safety of diuretics in therapy of hypertension]. (1997) (0)
Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system. (2005) (0)
1538 – CENTRAL BEHAVIORAL EFFECTS OF PUTATIVE NEUROTRANSMITTERS IN MICE (1977) (0)
Opiate-like peptides. Part XII. Synthesis and some biological properties of Met-enkephalin analogues modified in position 2 by D-alanyl residue in positions 2 and 4 by 3-(2-naphthyl)-D-alanyl residue. (1989) (0)
Central effects of a selective delta-opioid receptor antagonist, ICI 174864. (1986) (0)
[Preliminary pharmacological evaluation of 5-allyl-5-(beta-aminopropyl)-barbituric acid]. (1967) (0)
Th-P16:299 The treatment with fenofibrate decreases monocyte release of proinflammatory cytokines in dyslipidemic patients with impaired fasting glucose (2006) (0)
[Postparum thyroiditis]. (2006) (0)
1555 – THE INFLUENCE OF LONG TERM TREATMENT WITH NEUROLEPTICS ON KEY ENZYMES OP CHOLINERGIC SYSTEM IN RATS BRAIN (1978) (0)
D1 and TrkB Receptors Take Charge of the Molecular Antidepressant Action in Cultured Astroglial Cells (2013) (0)
Effect of buspirone on neuropeptide Y (NPY) content in rat brain (1999) (0)
[Effect of guanoxan and isocarboxazide on arteriosclerotic lesions induced experimentally in white rats of the Sprague-Dawley and Wistar strains]. (1968) (0)
The central action of gamma-aminobutyric acid in rats. (1977) (0)
Behavioral effects of apomorphine during development of rats. (1977) (0)
[Some pharmacological properties of 5-thiocarbamoylbarbituric acids]. (1967) (0)
1539 – CENTRAL AND PERIPHERAL EFFECTS OF NORADRENALINE AND DIBUTYRYL CYCLIC AMP AFTER 6-HYDR0XYD0PAMINE (1977) (0)
[Biogenic amines and their metabolites in brain tumor tissue]. (1984) (0)
Effect of captopril and thiorphan on the proliferation of human neoplastic cell lines and their influence on cytostatic activity of interferon alpha or cytotoxic activity of doxorubicin. (1995) (0)
[Drug therapy of angina pectoris]. (1981) (0)
[Clinical research on drugs]. (1978) (0)
W09.246 Impaired glucose tolerance as an important risk factor of atherosclerosis (2004) (0)
Influence of ketamine on the analgesic efficacy of the agonist-antagonist opioids (1992) (0)
[Primary hyperparathyroidism]. (2005) (0)
Enhanced responses to muscarine in rats treated chronically with atropine. (1981) (0)
The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats. (1991) (0)
5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs. (1975) (0)
[The effect of astrocytoma cells on secretion of cytokines by autologous lymphocytes]. (1999) (0)
Changes in the central nervous system of the parental generation of rats after chronic intoxication with lead and cadmium (1980) (0)
Scyliorhinin I and its analogues modified in positions 7 and 8: Synthesis, activity in GPI test, and circular dichroism (1991) (0)
Main research trends in Polish pharmacology in the years 1965-1985. (1986) (0)
W15.418 Extralipid effects of atorvastatin in patients with hypercholesterolemia (2004) (0)
[Pathomorphological changes in rat internal organs following long-term administration of neuroleptics]. (1978) (0)
[Anabolic therapy of osteoporosis]. (2005) (0)
[The pharmacology of pain]. (1986) (0)
Effects of apomorphine and clonidine on the cerebral cholinergic system. (1977) (0)
1177 – ABSTINENCE SYNDROM AFTER LONG-TERM TREATMENT WITH FLUPHENAZINE (1977) (0)
Spinal effects of alpha-endorphin in mice. (1986) (0)
Behavioral effects of dibutyryl cyclic 3'5'AMP and biogenic amines in rats. (1975) (0)
[Pathomorphological changes in the internal organs of rats after long-term administration of oxazepam and protriptyline]. (1981) (0)
The principles of controlled clinical trials of drugs. (1978) (0)
Depressant action of metabolities of noradrenaline and adrenaline in rats. (1973) (0)
[Normoaldosterone spironolactone sensitive hypertension]. (2006) (0)
The comparison of the influence of the central cholinergic system on the catalepsy induced by neuroleptics or opioids. (1986) (0)
Synthesis and Structure-Activity Relationship of Scyliorhinin I Analogues Modified in Positions 3, 6, 7 and 8. (1993) (0)
Chronotherapy with aminoglycosides in elderly (1990) (0)
2200 – IS THE 5-HYDROXYTRYPTAMINE INVOLVED IN SOME CENTRAL EFFECTS OF PROSTAGLANDINS IN RATS? (1978) (0)
[Modern medical therapy of acromegaly]. (2005) (0)
[The role of calcium-sensing receptors in physiology, pathology and therapy]. (2003) (0)
Effects of clonidine and apomorphine on motor and exploratory activity in mice with frontal lobe lesions. (1978) (0)
The new diagnostic approache in atherosclerosis management (2001) (0)
The concentration of gamma-aminobutyric acid (GABA) in discrete areas of rat brain after chemical sympathectomy or serotoninectomy. (1980) (0)
Influence of Neuroleptics on Cytotoxic Activity of Rat Natural Killer Cells (1998) (0)
[Release of papaverine and atropine from various suppository bases in vitro]. (1983) (0)
[Proatherogenic lipid metabolism disturbances in impaired glucose tolerance]. (2005) (0)
[Role of acetylcholine in the action of the brain and action of drugs]. (1973) (0)
Synthesis and biological activity in the GPI test of scyliorhinin I and its Val7 and Ile7 analogs. (1992) (0)
Th-P16:363 Effect of atorvastatin on interleukin 1 beta gene expression and monocyte release (2006) (0)
[Precocious puberty]. (2006) (0)
[Studies on the effect of derivatives of boradioxacyclopentane and boradioxacyclohexane on animal behavior]. (1968) (0)
[Neuropathological changes in rat brain following long-term treatment with neuroleptics, oxazepam and protryptyline]. (1978) (0)
[THE EFFECT OF CERTAIN PHRENOTROPIC COMPOUNDS ON THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS]. (1964) (0)
1557 – THE CONCENTRATION OF HOMOVANILLIC ACID AND 5-HYDROXYINDOLEACETIC ACID IN THE CEREBRO-SPINAL FLUID OF LATERAL VENTRICLE OF BRAIN OF PATIENTS WITH OCCLUSIVE HYDROCEPHALUS (1978) (0)
Behavioural effects of dopamine and 5-hydroxytryptamine in centrally chemosympathectomized rats. (1976) (0)
Clinical research on drugs (1978) (0)
The simvastatin therapy may change the secretion of tumor necrosis factor by human macrophages (1999) (0)
Main research trends in Polish pharmacology in the years 1965-1985. (1986) (0)
[End-to-end anastomosis of the splenic and proximal renal veins for the treatment of portal hypertension]. (1982) (0)
[Clinical pathological features of small renal cell cancer: a single-center experience on 1 267 cases]. (2014) (0)
[Preliminary pharmacological evaluation of 5-allyl-5-(beta-aminopropyl)-barbituric acid]. (1967) (0)
Influence of enflurane and isoflurane on some indicatory enzymes of the cerebellar cortex (1995) (0)
Drug therapy of angina pectoris (1981) (0)
Metabolism of enkephalins in rat brain after chronic administration of neuroleptics (1990) (0)
Enkephalins and the action of psychotropic drugs. (1987) (0)
Role of acetylcholine in the action of the brain and action of drugs (1973) (0)
Direct vision controlled gastric coronary vein embolization for the treatment of portal hypertension. (1990) (0)
Role of catecholamines and their metabolism in the activity of the brain (1971) (0)
The role of catecholamines and acetylcholine in the regulation of animal behaviour. (1980) (0)
The pharmacology of pain (1986) (0)
3.P.395 The release of cytokines by cultured macrophages from hyperlipidemic patients treated with micronized fenofibrate (1997) (0)
[Importance of the discovery of endorphins and enkephalins for present-day psychopharmacology]. (1983) (0)
The influence of psychotropic drugs on the level and metabolism of noradrenaline in brain and behavior of rats. (1970) (0)
2445 – CENTRAL EFFECTS OF CATECHOLAMINES ON CIRCULATORY SYSTEM IN RATS (1978) (0)
30 years of the Ludwik Waryński Silesian Medical Academy--the history and development of the department of pharmacology. (1978) (0)
5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs. (1975) (0)
Leucine enkephalin level in rat hypothalamus, striatum, hippocampus and adrenal glands in experimental rat uremia. (1995) (0)
Effects of intrahypothalamic injections of kainic acid on the behaviour of rats. (1981) (0)
1554 – INFLUENCE OP MICROINJECTION OF 6-HYDROXYDOPA /6 OH-DOPA/ INTO THE HYPOTHALAMUS AND HIPPOCAMPUS ON THE BEHAVIOUR AND THE LEVEL OP BIOGENIC AMINES IN THE RAT BRAIN (1978) (0)
[Behavior of rats at different phases of the sexual cycle]. (1974) (0)
Behavior of rats in various stages of the sexual cycle after injection of noradrenaline into the lateral ventricle of the brain. (1977) (0)
Participation of central adrenergic and cholinergic neurons in the development of the behavioural despair test in rats. (1982) (0)
1541 – THE LEARNING OP THE CONDITIONED AVOIDANCE REFLEX /CAR/ IN RATS WITH DIFFERENT L0C0M0T0R ACTIVITY LEVEL AND AFTER 6-HYDROXYDOFAMINE /6-0HDA/ (1977) (0)
[Cyclic GMP and its role in intracellular transmission of biological information]. (1975) (0)

This paper list is powered by the following services:

Other Resources About Zbigniew Herman

en.wikipedia.org

What Schools Are Affiliated With Zbigniew Herman?

Zbigniew Herman is affiliated with the following schools:

Zbigniew Herman's Academic­Influence.com Rankings

Zbigniew Herman's Degrees

Why Is Zbigniew Herman Influential?

Zbigniew Herman's Published Works

Published Works

Other Resources About Zbigniew Herman

What Schools Are Affiliated With Zbigniew Herman?

Zbigniew Herman's AcademicInfluence.com Rankings